Search Results - "HIEBSCH, RONALD, R" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinoma

Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinoma

by Xiao, Zhenyu, Chung, Haniee, Banan, Babak, Manning, Pamela T, Ott, Katherine C, Lin, Shin, Capoccia, Benjamin J, Subramanian, Vijay, Hiebsch, Ronald R, Upadhya, Gundumi A, Mohanakumar, Thalachallour, Frazier, William A, Lin, Yiing, Chapman, William C
Published in Cancer letters (01.05.2015)

Get full text

Journal Article

Novel SIRPα Antibodies That Induce Single-Agent Phagocytosis of Tumor Cells while Preserving T Cells

Novel SIRPα Antibodies That Induce Single-Agent Phagocytosis of Tumor Cells while Preserving T Cells

by Andrejeva, Gabriela, Capoccia, Benjamin J, Hiebsch, Ronald R, Donio, Michael J, Darwech, Isra M, Puro, Robyn J, Pereira, Daniel S
Published in The Journal of immunology (1950) (15.02.2021)

Get full text

Journal Article

Development of AO-176, a Next-Generation Humanized Anti-CD47 Antibody with Novel Anticancer Properties and Negligible Red Blood Cell Binding

Development of AO-176, a Next-Generation Humanized Anti-CD47 Antibody with Novel Anticancer Properties and Negligible Red Blood Cell Binding

by Puro, Robyn J, Bouchlaka, Myriam N, Hiebsch, Ronald R, Capoccia, Benjamin J, Donio, Michael J, Manning, Pamela T, Frazier, William A, Karr, Robert W, Pereira, Daniel S
Published in Molecular cancer therapeutics (01.03.2020)

Get full text

Journal Article

CD47 blockade reduces ischemia/reperfusion injury and improves survival in a rat liver transplantation model

CD47 blockade reduces ischemia/reperfusion injury and improves survival in a rat liver transplantation model

by Xiao, Zhen‐Yu, Banan, Babak, Jia, Jianluo, Manning, Pamela T., Hiebsch, Ronald R., Gunasekaran, Muthukumar, Upadhya, Gundumi A., Frazier, William A., Mohanakumar, Thalachallour, Lin, Yiing, Chapman, William C.
Published in Liver transplantation (01.04.2015)

Get full text

Journal Article

CD47 blockade reduces ischemia-reperfusion injury and improves outcomes in a rat kidney transplant model

CD47 blockade reduces ischemia-reperfusion injury and improves outcomes in a rat kidney transplant model

by Lin, Yiing, Manning, Pamela T, Jia, Jianluo, Gaut, Joseph P, Xiao, Zhenyu, Capoccia, Benjamin J, Chen, Chun-Cheng, Hiebsch, Ronald R, Upadhya, Gundumi, Mohanakumar, Thalachallour, Frazier, William A, Chapman, William C
Published in Transplantation (27.08.2014)

Get more information

Journal Article

Attenuation of Ischemia-Reperfusion Injury and Improvement of Survival in Recipients of Steatotic Rat Livers Using CD47 Monoclonal Antibody

Attenuation of Ischemia-Reperfusion Injury and Improvement of Survival in Recipients of Steatotic Rat Livers Using CD47 Monoclonal Antibody

by Xiao, Zhenyu, Banan, Babak, Xu, Min, Jia, Jianluo, Manning, Pamela T, Hiebsch, Ronald R, Gunasekaran, Muthukumar, Upadhya, Gundumi A, Frazier, William A, Mohanakumar, Thalachallour, Lin, Yiing, Chapman, William C
Published in Transplantation (01.07.2016)

Get more information

Journal Article

Piperazinyl-glutamate-pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregation

Piperazinyl-glutamate-pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregation

by PARLOW, John J, BURNEY, Mary W, WOERNDLE, Rhonda S, ENNIS, Michael D, CASE, Brenda L, GIRARD, Thomas J, HALL, Kerri A, HIEBSCH, Ronald R, HUFF, Rita M, LACHANCE, Rhonda M, MISCHKE, Deborah A, RAPP, Stephen R
Published in Bioorganic & medicinal chemistry letters (15.08.2009)

Get full text

Journal Article

Piperazinyl-glutamate-pyrimidines as potent P2Y12 antagonists for inhibition of platelet aggregation

Piperazinyl-glutamate-pyrimidines as potent P2Y12 antagonists for inhibition of platelet aggregation

by PARLOW, John J, BURNEY, Mary W, WOERNDLE, Rhonda S, ENNIS, Michael D, CASE, Brenda L, GIRARD, Thomas J, HALL, Kerri A, HIEBSCH, Ronald R, HUFF, Rita M, LACHANCE, Rhonda M, MISCHKE, Deborah A, RAPP, Stephen R
Published in Bioorganic & medicinal chemistry letters (01.11.2009)

Get full text

Journal Article

Part II: Piperazinyl-glutamate-pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregation

Part II: Piperazinyl-glutamate-pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregation

by PARLOW, John J, BURNEY, Mary W, RAPP, Stephen R, WOERNDLE, Rhonda S, ENNIS, Michael D, CASE, Brenda L, GIRARD, Thomas J, HALL, Kerri A, HARRIS, Peter K, HIEBSCH, Ronald R, HUFF, Rita M, LACHANCE, Rhonda M, MISCHKE, Deborah A
Published in Bioorganic & medicinal chemistry letters (15.02.2010)

Get full text

Journal Article

Caspase Activation in MCF7 Cells Responding to Etoposide Treatment

Caspase Activation in MCF7 Cells Responding to Etoposide Treatment

by Benjamin, C W, Hiebsch, R R, Jones, D A
Published in Molecular pharmacology (01.03.1998)

Get full text

Journal Article

AO-176, a Differentiated Clinical-Stage Anti-CD47 Antibody, Demonstrates Potent Anti-Tumor Activity across Multiple Preclinical Models of B Cell Neoplasms

AO-176, a Differentiated Clinical-Stage Anti-CD47 Antibody, Demonstrates Potent Anti-Tumor Activity across Multiple Preclinical Models of B Cell Neoplasms

by Wilson, William Casey, Richards, John O, Andrejeva, Gabriela, Capoccia, Benjamin J, Puro, Robyn J, Donio, Mike J, Hiebsch, Ronald R, Kashyap, Arun K, Pereira, Daniel S
Published in Blood (23.11.2021)

Get full text

Journal Article

Abstract 954: AO-176, a highly differentiated clinical stage anti-CD47 antibody, is efficacious in pre-clinical models of lymphoma

Abstract 954: AO-176, a highly differentiated clinical stage anti-CD47 antibody, is efficacious in pre-clinical models of lymphoma

by Capoccia, Benjamin J., Donio, Michael J., Richards, John O., Hiebsch, Ronald R., Puro, Robyn J., Kashyap, Arun K., Pereira, Daniel S.
Published in Cancer research (Chicago, Ill.) (01.07.2021)

Get full text

Journal Article

AO-176, a Highly Differentiated Clinical Stage Anti-CD47 Antibody, Exerts Potent Anti-Tumor Activity in Preclinical Models of Multiple Myeloma As a Single Agent and in Combination with Approved Therapeutics

AO-176, a Highly Differentiated Clinical Stage Anti-CD47 Antibody, Exerts Potent Anti-Tumor Activity in Preclinical Models of Multiple Myeloma As a Single Agent and in Combination with Approved Therapeutics

by Wilson, William Casey, Richards, John, Puro, Robyn J, Andrejeva, Gabriela, Capoccia, Ben J, Donio, Mike J, Hiebsch, Ronald R, Chakraborty, Prabir, Sung, Victoria, Pereira, Daniel S
Published in Blood (05.11.2020)

Get full text

Journal Article

Highly Differentiated Anti-CD47 Antibody, AO-176, Potently Inhibits Hematologic Malignancies Alone and in Combination

Highly Differentiated Anti-CD47 Antibody, AO-176, Potently Inhibits Hematologic Malignancies Alone and in Combination

by Richards, John, Bouchlaka, Myriam N, Puro, Robyn J, Capoccia, Ben J, Hiebsch, Ronald R, Donio, Michael J, Wilson, W. Casey, Chakraborty, Prabir, Sung, Victoria, Pereira, Daniel S
Published in Blood (13.11.2019)

Get full text

Journal Article

Abstract 548: Evaluation of novel SIRP antibodies as potential cancer therapeutics

Abstract 548: Evaluation of novel SIRP antibodies as potential cancer therapeutics

by Hiebsch, Ronald R., Bouchlaka, Myriam N., Capoccia, Benjamin J., Donio, Michael J., Chakraborty, Prabir, Wilson, W. Casey, Puro, Robyn J., Pereira, Daniel S.
Published in Cancer research (Chicago, Ill.) (01.07.2019)

Get full text

Journal Article

Abstract 540: AO-176, a normal cell sparing humanized anti-CD47 antibody

Abstract 540: AO-176, a normal cell sparing humanized anti-CD47 antibody

by Chakraborty, Prabir, Bouchlaka, Myriam N., Capoccia, Benjamin J., Hiebsch, Ronald R., Donio, Michael J., Puro, Robyn J., Sung, Vicki, Pereira, Daniel S.
Published in Cancer research (Chicago, Ill.) (01.07.2019)

Get full text

Journal Article

Therapeutic Potential of AO-176, a Next Generation Humanized CD47 Antibody, for Hematologic Malignancies

Therapeutic Potential of AO-176, a Next Generation Humanized CD47 Antibody, for Hematologic Malignancies

by Wilson, W. Casey, Bouchlaka, Myriam N, Capoccia, Ben J, Hiebsch, Ronald R, Donio, Michael J, Puro, Robyn J, Carter, Alun J, Chakraborty, Prabir, Manning, Pamela T, Karr, Robert W, Sung, Vicki, Pereira, Daniel S
Published in Blood (29.11.2018)

Get full text

Journal Article

Dual-Function Anti-CD47mAbs Induce Tumor Cell Death and Promote Phagocytosis Resulting in Enhanced in Vivo Efficacy

Dual-Function Anti-CD47mAbs Induce Tumor Cell Death and Promote Phagocytosis Resulting in Enhanced in Vivo Efficacy

by Manning, Pamela T., Capoccia, Benjamin J., Rettig, Michael P., Hiebsch, Ronald R., Karr, Robert W., DiPersio, John F., Frazier, William A.
Published in Blood (06.12.2014)

Get full text

Journal Article

Piperazinyl Glutamate Pyridines as Potent Orally Bioavailable P2Y(12) Antagonists for Inhibition of Platelet Aggregation

Piperazinyl Glutamate Pyridines as Potent Orally Bioavailable P2Y(12) Antagonists for Inhibition of Platelet Aggregation

by Parlow, John J., Burney, Mary W., Case, Brenda L., Girard, Thomas J., Hall, Kerri A., Harris, Peter K., Hiebsch, Ronald R., Huff, Rita M., Lachance, Rhonda M., Mischke, Deborah A., Rapp, Stephen R., Woerndle, Rhonda S., Ennis, Michael D.
Published in Journal of medicinal chemistry (11.03.2010)

Get full text

Journal Article

Vesicle fusion in protein transport through the Golgi in vitro does not involve long-lived prefusion intermediates. A reassessment of the kinetics of transport as measured by glycosylation

Vesicle fusion in protein transport through the Golgi in vitro does not involve long-lived prefusion intermediates. A reassessment of the kinetics of transport as measured by glycosylation

by Hiebsch, Ronald R, Wattenberg, Binks W
Published in Biochemistry (Easton) (01.07.1992)

Get full text

Journal Article